跳转至内容
Merck
CN

V-011

维生素A标准液 溶液

100 μg/mL ± 25% (Refer to COA) (Ethanol with 0.1% (w/v) BHT), ampule of 1 mL, reference material, Cerilliant®

别名:

视黄醇 溶液, 3,7-二甲基-9-（2,6,6-三甲基-1-环己烯基）-2,4,6,8-九萘-1-醇, 全反式-视黄醇, 抗干眼醇, 维生素 A 醇 溶液, 维生素 A1

登录 查看公司和协议定价

选择尺寸

关于此项目

经验公式（希尔记法）:
C20H30O
化学文摘社编号:
68-26-8
分子量:
286.45
Beilstein:
403040
MDL编号:
MFCD00001552
UNSPSC代码:
41116107
PubChem化学物质编号:
329828922
NACRES:
NA.24

主要文件

查看所有文档
技术服务
需要帮助？我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助？我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

等级

reference material

质量水平

200

表单

liquid

特点

(Snap-N-Shoot®)
 (Snap-N-Spike®)

包装

ampule of 1 mL

制造商/商品名称

Cerilliant®

浓度

100 μg/mL ± 25% (Refer to COA) (Ethanol with 0.1% (w/v) BHT)

应用

clinical testing
clinical testing

包装形式

single component solution

储存温度

−70°C

SMILES字符串

CC(=C/CO)\C=C\C=C(C)\C=C\C1=C(C)CCCC1(C)C

InChI

1S/C20H30O/c1-16(8-6-9-17(2)13-15-21)11-12-19-18(3)10-7-14-20(19,4)5/h6,8-9,11-13,21H,7,10,14-15H2,1-5H3/b9-6+,12-11+,16-8+,17-13+

InChI key

FPIPGXGPPPQFEQ-OVSJKPMPSA-N

正在寻找类似产品? 访问 产品对比指南

相关类别

特点和优势

  • 按照ISO/IEC 17025和ISO 17034认证标准充分鉴定
  • 附带全面的分析证书(CoA)，提供稳定性、均一性、浓度准确性、不确定性和可追溯性方面的数据
  • 通过实时稳定性研究进行严格检测，确保准确性和保质期
  • 采用合格的精密天平通过重量法制备而成，最大限度减小不确定性
  • 在氩气保护下火焰密封安瓿瓶，确保长期保存
  • 为提高实验室效率，以便利、DEA豁免的形式提供

法律信息

CERILLIANT is a registered trademark of Merck KGaA, Darmstadt, Germany
Snap-N-Shoot is a registered trademark of Cerilliant Corporation
Snap-N-Spike is a registered trademark of Merck KGaA, Darmstadt, Germany

象形图

FlameExclamation mark
GHS02,GHS07

警示用语：

Danger

危险声明

H225,H319

危险分类

Eye Irrit. 2 - Flam. Liq. 2

储存分类代码

3 - Flammable liquids

WGK

WGK 1

闪点(°F)

57.2 °F

闪点(°C)

14.0 °C

法规信息

危险化学品
此项目有

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our 文件 section.

如需帮助，请联系 客户支持

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

Sarmila Mazumder et al.
Lancet (London, England), 385(9975), 1333-1342 (2014-12-17)
Vitamin A supplementation in children aged 6 months to 5 years has been shown to reduce mortality. The efficacy of neonatal supplementation with vitamin A to reduce mortality in the first 6 months of life is plausible but not established.
Gretchen A Stevens et al.
The Lancet. Global health, 3(9), e528-e536 (2015-08-16)
Vitamin A deficiency is a risk factor for blindness and for mortality from measles and diarrhoea in children aged 6-59 months. We aimed to estimate trends in the prevalence of vitamin A deficiency between 1991 and 2013 and its mortality
Karen M Edmond et al.
Lancet (London, England), 385(9975), 1315-1323 (2014-12-17)
Results of randomised controlled trials of newborn (age 1-3 days) vitamin A supplementation have been inconclusive. The WHO is coordinating three large randomised trials in Ghana, India, and Tanzania (Neovita trials). We present the findings of the Neovita trial in
Marieke R Beijer et al.
Immunology, 142(1), 39-45 (2014-05-21)
Vitamin A and its active metabolite retinoic acid are essential for the development and function of many tissues including the immune system. The induction of mucosal homing receptors on T and B cells by mucosal dendritic cells (DC) depends on
Inong R Gunanti et al.
The Journal of nutrition, 144(4), 489-495 (2014-02-07)
Mexican-American children have a high prevalence of overweight/obesity. Micronutrient deficiencies may be contributing to the development of greater adiposity in these children. This study investigated the relations between adiposity and serum concentrations of carotenoids, retinol, and vitamin E among Mexican-American
查看所有相关文献

实验方案

HPLC Analysis of Vitamins, Fat Soluble (A and E), on SUPELCOSIL™ LC-18

Separation of δ-Tocopherol, analytical standard; Retinyl acetate; (+)-γ-Tocopherol; α-Tocopherol, ≥95.5%; Retinol; Vitamin A (acetate), meets USP testing specifications.

我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持